1248.5.01006 Boehringer Ingelheim Investigational Site

Rochester, New York

0 studies enrolling now · 1 studies all time

What they study most

Asthma

Studies at this site

• Dose Finding Study on BI54903 (Inhaled Corticosteroid) Administered Twice Daily Via Respimat® Inhaler in Asthmatic Patients Inadequately Controlled on Short-acting-beta-agonist (SABA) Therapy — Stopped early